{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T17:44:49Z","timestamp":1790531089163,"version":"4.1.0"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T00:00:00Z","timestamp":1484265600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Targ Oncol"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1007\/s11523-016-0474-1","type":"journal-article","created":{"date-parts":[[2017,1,13]],"date-time":"2017-01-13T07:41:24Z","timestamp":1484293284000},"page":"211-218","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clinical Implications of Cytotoxic T Lymphocyte Antigen-4 Expression on Tumor Cells and Tumor-Infiltrating Lymphocytes in Extrahepatic Bile Duct Cancer Patients Undergoing Surgery Plus Adjuvant Chemoradiotherapy"],"prefix":"10.1007","volume":"12","author":[{"given":"Yu Jin","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaemoon","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyubo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eui Kyu","family":"Chie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sehui","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Bun","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Young","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Whe","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Do-Youn","family":"Oh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yung-Jue","family":"Bang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,13]]},"reference":[{"key":"474_CR1","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.cld.2007.11.003","volume":"12","author":"BR Blechacz","year":"2008","unstructured":"Blechacz BR, Gores GJ. Cholangiocarcinoma. Clin Liver Dis. 2008;12:131\u201350.","journal-title":"Clin Liver Dis"},{"key":"474_CR2","unstructured":"American Cancer Society. Bile duct cancer (cholangiocarcinoma). 2016. http:\/\/www.cancer.org\/acs\/groups\/cid\/documents\/webcontent\/003084-pdf.pdf . Accessed 29 Sept 2016."},{"key":"474_CR3","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/j.ijrobp.2009.12.031","volume":"79","author":"JH Park","year":"2011","unstructured":"Park JH, Choi EK, Ahn SD, et al. Postoperative chemoradiotherapy for extrahepatic bile duct cancer. Int J Radiat Oncol Biol Phys. 2011;79:696\u2013704.","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"474_CR4","doi-asserted-by":"crossref","unstructured":"Kim MY, Kim JH, Kim Y, Byun SJ. Postoperative radiotherapy appeared to improve the disease free survival rate of patients with extrahepatic bile duct cancer at high risk of loco-regional recurrence. Radiat Oncol J. 2016;34:297\u2013304.","DOI":"10.3857\/roj.2016.01879"},{"key":"474_CR5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","volume":"12","author":"DM Pardoll","year":"2012","unstructured":"Pardoll DM. The blockade of immune checkpoints in cancer immunotherapy. Nat Rev Cancer. 2012;12:252\u201364.","journal-title":"Nat Rev Cancer"},{"key":"474_CR6","doi-asserted-by":"crossref","first-page":"4762","DOI":"10.4049\/jimmunol.157.11.4762","volume":"157","author":"ML Alegre","year":"1996","unstructured":"Alegre ML, Noel PJ, Eisfelder BJ, et al. Regulation of surface and intracellular expression of CTLA4 on mouse T cells. J Immunol. 1996;157:4762\u201370.","journal-title":"J Immunol"},{"key":"474_CR7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1084\/jem.185.3.393","volume":"185","author":"PA Merwe van der","year":"1997","unstructured":"van der Merwe PA, Bodian DL, Daenke S, et al. CD80 (B7-1) binds both CD28 and CTLA-4 with a low affinity and very fast kinetics. J Exp Med. 1997;185:393\u2013403.","journal-title":"J Exp Med"},{"key":"474_CR8","doi-asserted-by":"crossref","first-page":"5813","DOI":"10.4049\/jimmunol.162.10.5813","volume":"162","author":"MC Brunner","year":"1999","unstructured":"Brunner MC, Chambers CA, Chan FK, et al. CTLA-4-mediated inhibition of early events of T cell proliferation. J Immunol. 1999;162:5813\u201320.","journal-title":"J Immunol"},{"key":"474_CR9","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/molehr\/5.1.84","volume":"5","author":"KA Kaufman","year":"1999","unstructured":"Kaufman KA, Bowen JA, Tsai AF, et al. The CTLA-4 gene is expressed in placental fibroblasts. Mol Hum Reprod. 1999;5:84\u20137.","journal-title":"Mol Hum Reprod"},{"key":"474_CR10","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1016\/j.humimm.2010.07.007","volume":"71","author":"S Laurent","year":"2010","unstructured":"Laurent S, Carrega P, Saverino D, et al. CTLA-4 is expressed by human monocyte-derived dendritic cells and regulates their functions. Hum Immunol. 2010;71:934\u201341.","journal-title":"Hum Immunol"},{"key":"474_CR11","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1007\/s00262-012-1211-y","volume":"61","author":"S Salvi","year":"2012","unstructured":"Salvi S, Fontana V, Boccardo S, et al. Evaluation of CTLA-4 expression and relevance as a novel prognostic factor in patients with non-small cell lung cancer. Cancer Immunol Immunother. 2012;61:1463\u201372.","journal-title":"Cancer Immunol Immunother"},{"key":"474_CR12","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1007\/s00262-015-1696-2","volume":"64","author":"H Yu","year":"2015","unstructured":"Yu H, Yang J, Jiao S, et al. Cytotoxic T lymphocyte antigen 4 expression in human breast cancer: implications for prognosis. Cancer Immunol Immunother. 2015;64:853\u201360.","journal-title":"Cancer Immunol Immunother"},{"key":"474_CR13","doi-asserted-by":"crossref","first-page":"728","DOI":"10.2174\/156800910793605811","volume":"10","author":"H Mao","year":"2010","unstructured":"Mao H, Zhang L, Yang Y, et al. New insights of CTLA-4 into its biological function in breast cancer. Curr Cancer Drug Targets. 2010;10:728\u201336.","journal-title":"Curr Cancer Drug Targets"},{"key":"474_CR14","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1038\/bjc.2013.610","volume":"109","author":"B Goeppert","year":"2013","unstructured":"Goeppert B, Frauenschuh L, Zucknick M, et al. Prognostic impact of tumour-infiltrating immune cells on biliary tract cancer. Br J Cancer. 2013;109:2665\u201374.","journal-title":"Br J Cancer"},{"key":"474_CR15","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.radonc.2015.07.003","volume":"117","author":"YJ Lim","year":"2015","unstructured":"Lim YJ, Koh J, Kim K, et al. High ratio of programmed cell death protein 1 (PD-1)(+)\/CD8(+) tumor-infiltrating lymphocytes identifies a poor prognostic subset of extrahepatic bile duct cancer undergoing surgery plus adjuvant chemoradiotherapy. Radiother Oncol. 2015;117:165\u201370.","journal-title":"Radiother Oncol"},{"key":"474_CR16","first-page":"3","volume":"2","author":"T Hothorn","year":"2002","unstructured":"Hothorn T, Lausen B. On maximally selected rank statistics. R News. 2002;2:3\u20135.","journal-title":"R News"},{"key":"474_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/bimj.200510161","volume":"48","author":"AL Boulesteix","year":"2006","unstructured":"Boulesteix AL. Maximally selected chi-square statistics for ordinal variables. Biom J. 2006;48:451\u201362.","journal-title":"Biom J"},{"key":"474_CR18","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0167-9473(02)00225-6","volume":"43","author":"T Hothorn","year":"2003","unstructured":"Hothorn T, Lausen B. On the exact distribution of maximally selected rank statistics. Comput Stat Data Anal. 2003;43:121\u201337.","journal-title":"Comput Stat Data Anal"},{"key":"474_CR19","doi-asserted-by":"crossref","first-page":"e51862","DOI":"10.1371\/journal.pone.0051862","volume":"7","author":"J Budczies","year":"2012","unstructured":"Budczies J, Klauschen F, Sinn BV, et al. Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimization. PLoS ONE. 2012;7:e51862.","journal-title":"PLoS ONE"},{"key":"474_CR20","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.ejca.2013.02.015","volume":"49","author":"RA Droeser","year":"2013","unstructured":"Droeser RA, Hirt C, Viehl CT, et al. Clinical impact of programmed cell death ligand 1 expression in colorectal cancer. Eur J Cancer. 2013;49:2233\u201342.","journal-title":"Eur J Cancer"},{"key":"474_CR21","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.lungcan.2015.05.007","volume":"89","author":"WA Cooper","year":"2015","unstructured":"Cooper WA, Tran T, Vilain RE, et al. PD-L1 expression is a favorable prognostic factor in early stage non-small cell carcinoma. Lung Cancer. 2015;89:181\u20138.","journal-title":"Lung Cancer"},{"key":"474_CR22","doi-asserted-by":"crossref","first-page":"e1792","DOI":"10.1038\/cddis.2015.162","volume":"6","author":"Y Jiang","year":"2015","unstructured":"Jiang Y, Li Y, Zhu B. T-cell exhaustion in the tumor microenvironment. Cell Death Dis. 2015;6:e1792.","journal-title":"Cell Death Dis"},{"key":"474_CR23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S1074-7613(00)80406-9","volume":"7","author":"CA Chambers","year":"1997","unstructured":"Chambers CA, Sullivan TJ, Allison JP. Lymphoproliferation in CTLA-4-deficient mice is mediated by costimulation-dependent activation of CD4+ T cells. Immunity. 1997;7:885\u201395.","journal-title":"Immunity"},{"key":"474_CR24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S1074-7613(00)80123-5","volume":"11","author":"P Shrikant","year":"1999","unstructured":"Shrikant P, Khoruts A, Mescher MF. CTLA-4 blockade reverses CD8+ T cell tolerance to tumor by a CD4+ T cell- and IL-2-dependent mechanism. Immunity. 1999;11:483\u201393.","journal-title":"Immunity"},{"key":"474_CR25","doi-asserted-by":"crossref","first-page":"4917","DOI":"10.1158\/1078-0432.CCR-12-1972","volume":"19","author":"CJ Nirschl","year":"2013","unstructured":"Nirschl CJ, Drake CG. Molecular pathways: coexpression of immune checkpoint molecules: signaling pathways and implications for cancer immunotherapy. Clin Cancer Res. 2013;19:4917\u201324.","journal-title":"Clin Cancer Res"},{"key":"474_CR26","first-page":"130","volume":"2","author":"M Cadamuro","year":"2013","unstructured":"Cadamuro M, Morton SD, Strazzabosco M, Fabris L. Unveiling the role of tumor reactive stroma in cholangiocarcinoma: an opportunity for new therapeutic strategies. Transl Gastrointest Cancer. 2013;2:130\u201344.","journal-title":"Transl Gastrointest Cancer"},{"key":"474_CR27","doi-asserted-by":"crossref","first-page":"803876","DOI":"10.1155\/2014\/803876","volume":"2014","author":"K Harada","year":"2014","unstructured":"Harada K, Nakanuma Y. Cholangiocarcinoma with respect to IgG4 reaction. Int J Hepatol. 2014;2014:803876.","journal-title":"Int J Hepatol"},{"key":"474_CR28","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1634\/theoncologist.12-7-864","volume":"12","author":"J Weber","year":"2007","unstructured":"Weber J. Review: anti-CTLA-4 antibody ipilimumab: case studies of clinical response and immune-related adverse events. Oncologist. 2007;12:864\u201372.","journal-title":"Oncologist"},{"key":"474_CR29","first-page":"5","volume":"13","author":"JF Grosso","year":"2013","unstructured":"Grosso JF, Jure-Kunkel MN. CTLA-4 blockade in tumor models: an overview of preclinical and translational research. Cancer Immun. 2013;13:5.","journal-title":"Cancer Immun"},{"key":"474_CR30","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1200\/JCO.2008.17.3567","volume":"26","author":"RL Camp","year":"2008","unstructured":"Camp RL, Neumeister V, Rimm DL. A decade of tissue microarrays: progress in the discovery and validation of cancer biomarkers. J Clin Oncol. 2008;26:5630\u20137.","journal-title":"J Clin Oncol"},{"key":"474_CR31","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1002\/ijc.27784","volume":"132","author":"YC Lin","year":"2013","unstructured":"Lin YC, Mahalingam J, Chiang JM, et al. Activated but not resting regulatory T cells accumulated in tumor microenvironment and correlated with tumor progression in patients with colorectal cancer. Int J Cancer. 2013;132:1341\u201350.","journal-title":"Int J Cancer"},{"key":"474_CR32","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/j.lungcan.2012.04.011","volume":"77","author":"N Erfani","year":"2012","unstructured":"Erfani N, Mehrabadi SM, Ghayumi MA, et al. Increase of regulatory T cells in metastatic stage and CTLA-4 over expression in lymphocytes of patients with non-small cell lung cancer (NSCLC). Lung Cancer. 2012;77:306\u201311.","journal-title":"Lung Cancer"}],"container-title":["Targeted Oncology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-016-0474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11523-016-0474-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11523-016-0474-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:40:54Z","timestamp":1692643254000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11523-016-0474-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,13]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["474"],"URL":"https:\/\/doi.org\/10.1007\/s11523-016-0474-1","relation":{},"ISSN":["1776-2596","1776-260X"],"issn-type":[{"value":"1776-2596","type":"print"},{"value":"1776-260X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,13]]}}}